Influenza
Conditions
Interventions
Sponsors
Chiba University Hospital
Shionogi Co. Ltd. The National Institute of Infectious Diseases
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria:
Exclusion criteria
Exclusion criteria: Persons who fall under any of the following 1)Patients who have received anti-influenza virus drugs within the past 7 days 2) Other persons deemed unsuitable by the research director
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Threshold value based on logistic regression and ROC analysis using specific antibody titer against influenza virus antigen and success/failure of virus isolation test | — |
Secondary
| Measure | Time frame |
|---|---|
| Sensitivity, specificity, and ROC-AUC were determined by logistic regression and ROC analysis using specific antibody titers against influenza virus antigens and the success or failure of virus isolation tests. | — |
Countries
Japan
Contacts
Public ContactMorio Nagira
Chiba University Hospital Department of Human Mucosal Vaccinology
Outcome results
None listed